跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,312 条关于
“Prothena Corporation plc”
全部
5,312
临床试验
951
药物
622
机构
2,212
资讯
1,527
上个月
Prothena to Report Second Quarter 2026 Financial Results on August 6
去年
Prothena Discontinues Birtamimab Development After Phase 3 Failure in AL Amyloidosis
去年
Prothena Cuts 63% of Workforce as Company Restructures Operations Amid Pipeline Milestones
去年
Prothena Faces Phase 3 Trial Setback in Neurodegenerative Disease Program
7个月前
Prothena Reports Q4 2025 Results as Neurodegeneration Pipeline Advances with Major Partnerships
去年
Prothena's Birtamimab Shows Promise in Phase 3 Trial for AL Amyloidosis with Focus on High-Risk Patients
3年前
hVIVO PLC Develops hMPV Human Challenge Model
10个月前
Coramitug Phase 2 Data Published in Circulation as Novo Nordisk Advances Phase 3 CLEOPATTRA Trial for ATTR Cardiomyopathy
去年
hVIVO Completes Pilot Study for Human Metapneumovirus (hMPV) Challenge Model
去年
COMPASS Pathways Reports Financials and Progress on COMP360 Psilocybin Program
第 1 页,共 153 页
上一页
下一页